España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Kronos Bio
KRON
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9579
0.03
3.21%
At close: -
$1.00
0.04
4.40%
After Hours: 7:15 PM EDT
Get Report
Comment
Kronos Bio (KRON) Forecast
News
Earnings
Kronos Bio (KRON) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Kronos Bio (NASDAQ:KRON) Stock
Kronos Bio Stock (NASDAQ: KRON)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 27, 2024
Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul
Nabaparna Bhattacharya
On November 22, Kronos Bio Board Approved App...
Benzinga Newsdesk
Friday, November 22, 2024
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Anthony Noto
Sunday, November 17, 2024
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Anthony Noto
Thursday, November 14, 2024
Kronos Bio Highlights Preclinical Data From p...
Benzinga Newsdesk
Piper Sandler Downgrades Kronos Bio to Neutra...
Benzinga Newsdesk
TD Cowen Downgrades Kronos Bio to Hold
Benzinga Newsdesk
Wednesday, November 13, 2024
Kronos Bio Q3 2024 GAAP EPS $(0.23) Beats $(0...
Benzinga Newsdesk
Tuesday, November 05, 2024
Kronos Bio To Present Data At The ASH Annual ...
Benzinga Newsdesk
Wednesday, October 23, 2024
Kronos Bio To Present Highlights On The Impor...
Benzinga Newsdesk
Tuesday, October 08, 2024
Piper Sandler Reiterates Overweight on Kronos...
Benzinga Newsdesk
Monday, October 07, 2024
Kronos Bio Announces Selection Of Autoimmune ...
Benzinga Newsdesk
Wednesday, September 25, 2024
Kronos Bio To Present Data At ACR Convergence...
Benzinga Newsdesk
Monday, September 23, 2024
Kronos Bio Highlights Preclinical Data At AAC...
Benzinga Newsdesk
Monday, August 19, 2024
HC Wainwright & Co. Reiterates Buy on Kronos ...
Benzinga Newsdesk
Thursday, August 08, 2024
Kronos Bio Q2 2024 EPS $(0.27), Sales $2.69M ...
Benzinga Newsdesk
Thursday, August 01, 2024
HC Wainwright & Co. Reiterates Buy on Kronos ...
Benzinga Newsdesk
Tuesday, July 23, 2024
First Patient Dosed In Kronos Bio's KB-0742, ...
Benzinga Newsdesk
Thursday, June 13, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Tuesday, June 11, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Friday, May 24, 2024
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Tuesday, May 21, 2024
Kronos Bio Appoints Deborah Knobelman As COO ...
Benzinga Newsdesk
Thursday, May 09, 2024
Kronos Bio Q1 2024 Adj EPS $(0.50) Misses $(0...
Benzinga Newsdesk
Friday, May 03, 2024
HC Wainwright & Co. Maintains Buy on Kronos B...
Benzinga Newsdesk
Wednesday, April 24, 2024
Kronos Bio To Present Clinical Update On Phas...
Benzinga Newsdesk
Thursday, March 21, 2024
Recap: Kronos Bio Q4 Earnings
Benzinga Insights
Kronos Bio Q4 EPS $(0.43) Beats $(0.52) Estim...
Benzinga Newsdesk
Thursday, March 07, 2024
Kronos Bio Announces 21% Reduction In Workforce, Restructuring To Focus Resources On Clinical Development With Extended Cash Runway Into The Second Half Of 2026
Happy Mohamed
Tuesday, March 05, 2024
Kronos Bio Amends Protocol For Its Trial Of K...
Benzinga Newsdesk
Thursday, January 25, 2024
Kronos Bio Eliminates Executive Officer Roles...
Benzinga Newsdesk
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, December 19, 2023
Cancer Player Kronos Bio To Stop Lanraplenib Combo Therapy Blood Cancer Study
Vandana Singh
Piper Sandler Maintains Overweight on Kronos ...
Benzinga Newsdesk
Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Kronos B...
Benzinga Newsdesk
Monday, December 18, 2023
Kronos Bio Says Phase 1b Portion Of Phase 1b/...
Bill Haddad
Monday, November 27, 2023
HC Wainwright & Co. Reiterates Buy on Kronos ...
Benzinga Newsdesk
Monday, November 20, 2023
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
Lisa Levin
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, November 16, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, November 13, 2023
Kronos Bio Q3 EPS $(0.54) Misses $(0.51) Esti...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, November 02, 2023
Kronos Bio Announces Plan To Optimize Resourc...
Benzinga Newsdesk
Kronos Bio Presents Preliminary Data From The...
Benzinga Newsdesk
Friday, October 27, 2023
Kronos Bio To Present Preliminary Data From P...
Benzinga Newsdesk
Friday, October 13, 2023
Kronos Bio Presents Preliminary Data From Pha...
Benzinga Newsdesk
Wednesday, October 04, 2023
Kronos Bio To Present Interim Data From Phase...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
